AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...
Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results